Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder ; volume:62 ; number:10 ; day:16 ; month:8 ; year:2023 ; pages:1427-1443 ; date:10.2023
Clinical pharmacokinetics ; 62, Heft 10 (16.8.2023), 1427-1443, 10.2023
- Urheber
-
Björnsson, Marcus
Acharya, Chayan
Strandgården, Kerstin
Tiberg, Fredrik
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-023-01288-6
- URN
-
urn:nbn:de:101:1-2023121311404969445370
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Björnsson, Marcus
- Acharya, Chayan
- Strandgården, Kerstin
- Tiberg, Fredrik
- SpringerLink (Online service)
Ähnliche Objekte (12)
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Physicians’ satisfaction with providing buprenorphine treatment
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Routes of non-traditional entry into buprenorphine treatment programs
Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Development and evaluation of a community-based buprenorphine treatment intervention
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Physicians’ satisfaction with providing buprenorphine treatment
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Routes of non-traditional entry into buprenorphine treatment programs
Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Development and evaluation of a community-based buprenorphine treatment intervention
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Physicians’ satisfaction with providing buprenorphine treatment
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Routes of non-traditional entry into buprenorphine treatment programs
Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series